A Leptin Dose-response Study in Obese (ob/ob) and Lean (+/?) Mice
Overview
Affiliations
This experiment determined the amount of leptin required to correct different abnormalities in leptin-deficient ob/ob mice. Baseline food intakes and body weights of lean (+/?) and obese (ob/ob) C57B1/6J <ob> mice were recorded for 7 days. An Alzet miniosmotic pump was placed in the peritoneal cavity of each mouse and delivered 0, 1, 2, 5, 10, or 42 microg/day human leptin for 7 days. In ob/ob mice, 2 microg leptin/day reduced food intake and body weight, and increased hypothalamic and brain stem serotonin concentrations. All fat pads were reduced 35-40% by 10 microg leptin/day, and liver weight, lipid, and glycogen decreased. Serum insulin and glucose were reduced in all leptin-treated ob/ob mice, and levels were normalized by 10 microg/day leptin. Low rectal temperatures of ob/ob mice were corrected by 10 and 42 microg/day leptin. These doses also increased brown adipose tissue uncoupling protein expression. The only responses in lean mice were a transient reduction in food intake and weight loss with 10 or 42 microg/day leptin. This study shows enhanced leptin sensitivity in ob/ob mice and suggests that increased temperature and sympathetic activity are indirect responses to high concentrations of protein.
TET2: the fat controller of leptin.
Goldsmith C, Dodd G Life Metab. 2025; 3(4):loae019.
PMID: 39872508 PMC: 11749346. DOI: 10.1093/lifemeta/loae019.
Interplay between the brain and adipose tissue: a metabolic conversation.
Diaz-Castro F, Morselli E, Claret M EMBO Rep. 2024; 25(12):5277-5293.
PMID: 39558137 PMC: 11624209. DOI: 10.1038/s44319-024-00321-4.
History and future of leptin: Discovery, regulation and signaling.
Munzberg H, Heymsfield S, Berthoud H, Morrison C Metabolism. 2024; 161:156026.
PMID: 39245434 PMC: 11570342. DOI: 10.1016/j.metabol.2024.156026.
Fernandez-Beltran L, Ali Z, Larrad-Sanz A, Lopez-Carbonero J, Godoy-Corchuelo J, Jimenez-Coca I Sci Rep. 2024; 14(1):2671.
PMID: 38302474 PMC: 10834470. DOI: 10.1038/s41598-024-52439-z.
Harris R Am J Physiol Endocrinol Metab. 2023; 325(1):E72-E82.
PMID: 37285599 PMC: 10292972. DOI: 10.1152/ajpendo.00083.2023.